Program Official

Principal Investigator

Yingye
Zheng
Awardee Organization

Fred Hutchinson Cancer Center
United States

Fiscal Year
2024
Activity Code
U24
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

The Early Detection Research Network: Data Management and Coordinating Center

The key for the Early Detection Research Network (EDRN)'s success lies in good communication among scientists in multiple disciplines; efficient evaluation and prioritization of promising biomarkers; and rigorous validation studies to demonstrate their clinical utility. The overall aims of the proposed renewal of the Data Management and Coordinating Center (DMCC) are to (i) provide coordination of EDRN in order to enhance communication and collaboration among EDRN investigators and with general scientific communities; (ii) coordinate EDRN validation studies and provide leadership in data science; (iii) disseminate cancer biomarker information to broader scientific communities and the public; and (iv) manage the EDRN Core funds. Under the direction of the EDRN Steering Committee, the DMCC will 1) perform network coordination and outreach and promote collaborations among scientific investigators by providing support for EDRN meetings and workshops, developing and maintaining EDRN secure websites and listservs, producing and maintaining all EDRN documents, and maintaining the online review system for applications submitted to the EDRN; 2) support EDRN validation studies by developing and maintaining validation study data management systems; working with EDRN investigators on study design, protocol development, data forms, and study manuals; coordinating and monitoring studies; tracking specimens; and performing QA/QC and study evaluation; and provide and promote best statistical and computational practices to EDRN studies; 3) work with the NCI and JPL to provide informatics resources for the EDRN Secure Web site for data security, data warehousing, and data sharing, and a Public Web site for dissemination; and 4) work closely with the EDRN SC and the NCI Project Coordinator and Fred Hutch OSR to timely activate the core funds after the EDRN SC approval and ensure the compliance of all regulatory requirements for sub-award management.

Publications

  • Liss MA, Zeltser N, Zheng Y, Lopez C, Liu M, Patel Y, Yamaguchi TN, Eng SE, Tian M, Semmes OJ, Lin DW, Brooks JD, Wei JT, Klein EA, Tewari AK, Mosquera JM, Khani F, Robinson BD, Aasad M, Troyer DA, Kagan J, Sanda MG, Thompson IM, Boutros PC, Leach RJ. Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2024 Nov 1;33(11):1500-1511. PMID: 39158404
  • Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME. Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 2024 May 1;79(5):1212-1219. Epub 2023 Nov 9. PMID: 38445559
  • Singal AG, Hoshida Y, Pinato DJ, Marrero J, Nault JC, Paradis V, Tayob N, Sherman M, Lim YS, Feng Z, Lok AS, Rinaudo JA, Srivastava S, Llovet JM, Villanueva A. International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma. Gastroenterology. 2021 Jun;160(7):2572-2584. Epub 2021 Mar 9. PMID: 33705745
  • Fahrmann JF, Bantis LE, Capello M, Scelo G, Dennison JB, Patel N, Murage E, Vykoukal J, Kundnani DL, Foretova L, Fabianova E, Holcatova I, Janout V, Feng Z, Yip-Schneider M, Zhang J, Brand R, Taguchi A, Maitra A, Brennan P, Max Schmidt C, Hanash S. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. Journal of the National Cancer Institute. 2019 Apr 1;111(4):372-379. PMID: 30137376
  • Li F, Wei F, Huang WL, Lin CC, Li L, Shen MM, Yan Q, Liao W, Chia D, Tu M, Tang JH, Feng Z, Kim Y, Su WC, Wong DTW. Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients. Cancers. 2020 Jul 24;12. (8). PMID: 32722209
  • Li W, Li R, Yan Q, Feng Z, Ning J. Conditional concordance-assisted learning under matched case-control design for combining biomarkers for population screening. Statistics in medicine. 2023 Apr 30;42(9):1398-1411. Epub 2023 Feb 2. PMID: 36733187
  • Irajizad E, Fahrmann JF, Marsh T, Vykoukal J, Dennison JB, Long JP, Do KA, Feng Z, Hanash S, Ostrin EJ. Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Sep 20;41(27):4360-4368. Epub 2023 Jun 28. PMID: 37379494
  • Shaukat A, Marsh TL, Crockett SD, Syngal S, Bresalier RS, Brenner DE. Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2022 Nov;20(11):2650-2652.e1. Epub 2021 Sep 20. PMID: 34547437
  • Tayob N, Feng Z. Personalized statistical learning algorithms to improve the early detection of cancer using longitudinal biomarkers. Cancer biomarkers : section A of Disease markers. 2022;33(2):199-210. PMID: 35213362
  • Tayob N, Lok ASF, Feng Z. A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers. Statistics in medicine. 2022 Jun 15;41(13):2338-2353. Epub 2022 Feb 23. PMID: 35199349
  • Park Y, Yuan Y, Ning J, Liu S, Feng Z. Hybrid design evaluating new biomarkers when there is an existing screening test. Statistics in medicine. 2021 Apr 15;40(8):2037-2054. Epub 2021 Feb 4. PMID: 33540472
  • Li R, Ning J, Feng Z. Estimation and inference of predictive discrimination for survival outcome risk prediction models. Lifetime data analysis. 2022 Apr;28(2):219-240. Epub 2022 Jan 21. PMID: 35061146
  • Borges KA, Dai J, Parikh ND, Schwartz M, Nguyen MH, Roberts LR, Befeler AS, Srivastava S, Rinaudo JA, Feng Z, Marrero JA, Reddy KR. Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network. Contemporary clinical trials. 2019 Jan;76:49-54. Epub 2018 Nov 12. PMID: 30439517
  • Hanash S. Lung cancer susceptibility beyond smoking history: opportunities and challenges. Translational lung cancer research. 2022 Jul;11(7):1230-1232. PMID: 35958329
  • Liu Y, Kaur S, Huang Y, Fahrmann JF, Rinaudo JA, Hanash SM, Batra SK, Singhi AD, Brand RE, Maitra A, Haab BB. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2020 Dec;29(12):2513-2523. Epub 2020 Jun 12. PMID: 32532830
  • Zheng Y, Wagner PD, Singal AG, Hanash SM, Srivastava S, Huang Y, Zhao YQ, Chari ST, Marquez G, Etizioni R, Marsh TL, Feng Z. Designing Rigorous and Efficient Clinical Utility Studies for Early Detection Biomarkers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2024 Sep 3;33(9):1150-1157. PMID: 39223980
  • Gao X, Shen W, Ning J, Feng Z, Hu J. Addressing patient heterogeneity in disease predictive model development. Biometrics. 2022 Sep;78(3):1045-1055. Epub 2021 Aug 1. PMID: 34184256
  • Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Mar 10;40(8):876-883. Epub 2022 Jan 7. PMID: 34995129